… Jacques Cosnes has received lectures fees from Abbvie and consulting fees from Vifor
Pharma. Tabassome Simon's institutions have received grants from AstraZeneca, Daiichi-Sankyo…

Crohn's disease (CD) is a chronic progressive destructive disease. Currently available
instruments measure disease activity at a specific point in time. An instrument to measure …

Current smoking protects against ulcerative colitis and, after onset of the disease, improves
its course, decreasing the need for colectomy. However, smoking increases the risk of …

Current smoking increases the risk of developing Crohn’s disease and worsens its course,
increasing the need for steroids, immunosuppressants, and re-operations. On the contrary, …

Background Ciclosporin and infliximab are potential rescue treatments to avoid colectomy
in patients with acute severe ulcerative colitis refractory to intravenous corticosteroids. We …

Background The Vienna classification of Crohn's disease (CD) distinguishes three patient
subgroups according to disease behavior: stricturing, penetrating, and inflammatory. Our aim …

In the West, the incidence and prevalence of inflammatory bowel diseases has increased in
the past 50 years, up to 8–14/100,000 and 120–200/100,000 persons, respectively, for …

Background & Aims: Celiac disease may be associated with autoimmune diseases. The aims
of the present study were to determine in celiac patients which factors modulate the risk of …

Background Reports of an increased risk of lymphoproliferative disorders in patients receiving
thiopurines for inflammatory bowel disease are controversial. We assessed this risk in a …

Complex interactions between the host and the gut microbiota govern intestinal homeostasis
but remain poorly understood. Here we reveal a relationship between gut microbiota and …